Volume 100, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Central nervous system (CNS) strongyloidiasis is a known but rare form of disseminated infection. The diagnosis is often made postmortem, with only five published cases of an antemortem diagnosis. We report two fatal cases of CNS strongyloidiasis diagnosed antemortem, with larvae visualized in the CNS sample in one case. Risk factors for disseminated strongyloidiasis common to both cases included origination from the Caribbean, underlying human T-lymphotropic virus-1 infection, and recent prednisone use. Both cases occurred in Canada, where the occurrence of is uncommon, and serve as a reminder to maintain a high index of suspicion in patients with epidemiologic or clinical risk factors for dissemination.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Centers for Disease Control and Prevention, 2014. Parasites—Strongyloides. Available at: https://www.cdc.gov/parasites/strongyloides/. Accessed April 9, 2018.
  2. Boggild A, Libman M, Greenaway C, McCarthy A, on behalf of the Committee to Advise on Tropical Medicine and Travel (CATMAT); , 2016. CATMAT statement on disseminated strongyloidiasis: prevention, assessment and management guidelines. Can Comm Dis Rep 42: 1219. [Google Scholar]
  3. Keiser PB, Nutman TB, , 2004. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208217. [Google Scholar]
  4. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC, , 2004. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. Can Med Assoc J 171: 479484. [Google Scholar]
  5. Bradley SL, Dines DE, Brewere NS, , 1978. Disseminated Strongyloides stercoralis in an immunosuppressed host. Mayo Clin Proc 53: 332335. [Google Scholar]
  6. Neefe LI, Pinilla O, Garagusi VF, Bauer H, , 1973. Disseminated strongyloidiasis with cerebral involvement: a complication of corticosteroid therapy. Am J Med 55: 832838. [Google Scholar]
  7. Meltzer RS, Singer C, Armstrong D, Mayer K, Knapper WH, , 1979. Antemortem diagnosis of central nervous system strongyloidiasis. Am J Med Sci 277: 9198. [Google Scholar]
  8. Belani A, Leptrone D, Shands JW, , 1987. Strongyloides meningitis. South Med J 80: 916918. [Google Scholar]
  9. Dutcher JP, Marcus SL, Tanowitz H, Wittner M, Fuks JZ, Wiernik PH, , 1990. Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphoma. Cancer 66: 24172420. [Google Scholar]
  10. Dokmeci O, Forshay B, Scholand SJ, , 2013. Worms on the brain: fatal meningoencephalitis from disseminated strongyloides infection. Conn Med 77: 3134. [Google Scholar]
  11. Purtilo DT, Meyers WM, Connor DH, , 1974. Fatal strongyloidiasis in immunosuppressed patients. Am J Med 56: 488493. [Google Scholar]
  12. Montes M, 2009. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 3: e456. [Google Scholar]
  13. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB, , 1981. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3: 397407. [Google Scholar]

Data & Media loading...

  • Received : 10 Oct 2018
  • Accepted : 10 Oct 2018
  • Published online : 09 Jan 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error